D-limonene exhibits superior antihyperalgesic effects in a β-cyclodextrin-complexed form in chronic musculoskeletal pain reducing Fos protein expression on spinal cord in mice

[Display omitted] •The pharmacological and chemical profile of Limonene (LIM) was improved by βCD.•Slurry complexation was the best method for forming the LIM- βCD complex.•The possible analgesic effect of LIM is modulated in the dorsal horn of the spinal cord. Chronic musculoskeletal pain is one of...

Full description

Saved in:

Bibliographic Details
Published in:	Neuroscience Vol. 358; pp. 158 - 169
Main Authors:	Araújo-Filho, Heitor G., Pereira, Erik W.M., Rezende, Marília M., Menezes, Paula P., Araújo, Adriano A.S., Barreto, Rosana S.S., Martins, Anita O.B.P.B., Albuquerque, Thaís R., Silva, Bruno A.F., Alcantara, Isabel S., Coutinho, Henrique D.M., Menezes, Irwin R.A., Quintans-Júnior, Lucindo J., Quintans, Jullyana S.S.
Format:	Journal Article
Language:	English
Published:	United States Elsevier Ltd 01-09-2017
Subjects:	Analgesics - therapeutic use Animals beta-Cyclodextrins - therapeutic use C-Fos Capsaicin - toxicity chronic pain cyclodextrin Cyclohexenes - therapeutic use D-limonene Disease Models, Animal Drug Combinations Drug Interactions fibromyalgia GABA Agents - therapeutic use Hyperalgesia - drug therapy Hyperalgesia - etiology Male Mice monoterpenes Muscle Strength - drug effects Muscle Strength - physiology Musculoskeletal Pain - chemically induced Musculoskeletal Pain - drug therapy Musculoskeletal Pain - pathology Nociception - drug effects Pain Measurement - drug effects Pain Measurement - methods Pain Threshold - drug effects Proto-Oncogene Proteins c-fos - metabolism Spinal Cord - drug effects Spinal Cord - metabolism Statistics, Nonparametric Terpenes - therapeutic use chronic pain FM cyclodextrin FLU TRM SC DSC fibromyalgia FTIR βCD C-Fos TRPV1 monoterpenes GC-MS D-limonene LIM MOR NMR CDs PC TG DTG GABA NAL LIM-βCD PM
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	[Display omitted] •The pharmacological and chemical profile of Limonene (LIM) was improved by βCD.•Slurry complexation was the best method for forming the LIM- βCD complex.•The possible analgesic effect of LIM is modulated in the dorsal horn of the spinal cord. Chronic musculoskeletal pain is one of the main symptoms found in Fibromyalgia with unclear etiology and limited pharmacological treatment. The aim of this study was to complex LIM in β-cyclodextrin (LIM-βCD) and then evaluate its antihyperalgesic effect in an animal model of chronic musculoskeletal pain. Differential scanning calorimetry and scanning electron microscopy was used for the characterization of the inclusion complex. Male Swiss mice were used for experimental procedures where mechanical hyperalgesia, thermal hyperalgesia, muscular strength, Fos immunofluorescence was studied after induction of hyperalgesia. Mechanism of action was also investigated through tail flick test and capsaicin-induced nociception. Endothermic events and morphological changes showed that the slurry complex method was the best method for the complexation. After induction of hyperalgesia, the oral administration of LIM-βCD (50mg/kg) significantly increased the paw withdrawal threshold compared to uncomplexed limonene. Fos immunofluorescence showed that both compounds significantly decreased the number of Fos-positive cells in the dorsal horn. In nociceptive tests, FLU was able to reverse the antinociceptive effect of LIM-βCD. After intraplantar administration of capsaicin, LIM was able to significantly decrease time to lick. LIM-βCD has antihyperalgesic action superior to its uncomplexed form, with possible action in the dorsal horn of the spinal cord. These results suggest the possible applicability of LIM, uncomplexed or complexed with βCD, in conditions such as FM and neuropathic pain, for which there are currently only limited pharmacological options.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0306-4522 1873-7544
DOI:	10.1016/j.neuroscience.2017.06.037